Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning

Area of Science:

• Pediatric Hematology
• Immunology
• Transplantation Science

Background:

• Congenital immunodeficiencies (CIDs) are rare genetic disorders impairing the immune system.
• Stem cell transplantation (SCT) is a potential curative therapy for CIDs.
• The optimal conditioning regimen for SCT in pediatric CIDs remains undetermined.

Purpose of the Study:

• To evaluate the efficacy and safety of reduced-intensity conditioning (RIC) for SCT in children with CIDs.
• To compare outcomes of RIC-SCT with conventional SCT in this population.
• To assess graft-versus-host disease (GVHD), viral reactivation, immune reconstitution, and survival rates.

Main Methods:

• Retrospective analysis of 81 children with immunodeficiency undergoing 82 SCTs using RIC.
• Data collection on GVHD incidence, viral reactivation (including Epstein-Barr virus [EBV]), immune reconstitution markers, and survival.
• Comparison of outcomes based on donor type and disease severity (severe combined immunodeficiency [SCID] vs. non-SCID).

Main Results:

• Low incidence of significant GVHD was observed.
• Viral reactivation was common, with a notable increase in EBV reactivation.
• Immune reconstitution was comparable across different donor groups and to conventional SCT.
• Overall survival rate was 84% (68/81 children), with no significant differences between donor types or disease categories.
• RIC demonstrated a potential survival advantage over conventional SCT in the unrelated donor setting.

Conclusions:

• RIC is a viable and effective conditioning regimen for SCT in children with CIDs.
• While viral reactivation, particularly EBV, requires monitoring, RIC offers comparable immune reconstitution and survival to conventional SCT.
• RIC-SCT, especially with unrelated donors, may offer a significant survival benefit for pediatric CID patients.